Wang S - Search Results

1

Pramipexole derivatives as potent and selective dopamine D(3) receptor agonists with improved human microsomal stability.

Chen J, Jiang C, Levant B, Li X, Zhao T, Wen B, Luo R, Sun D, Wang S. Chen J, et al. Among authors: wang s. ChemMedChem. 2014 Dec;9(12):2653-60. doi: 10.1002/cmdc.201402398. Epub 2014 Oct 22. ChemMedChem. 2014. PMID: 25338762 Free PMC article.

2

Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.

Varady J, Wu X, Fang X, Min J, Hu Z, Levant B, Wang S. Varady J, et al. Among authors: wang s. J Med Chem. 2003 Oct 9;46(21):4377-92. doi: 10.1021/jm030085p. J Med Chem. 2003. PMID: 14521403

3

Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligands.

Wu X, Chen J, Ji M, Varady J, Levant B, Wang S. Wu X, et al. Among authors: wang s. Bioorg Med Chem Lett. 2004 Dec 6;14(23):5813-6. doi: 10.1016/j.bmcl.2004.09.047. Bioorg Med Chem Lett. 2004. PMID: 15501046

4

Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics.

Sun H, Nikolovska-Coleska Z, Chen J, Yang CY, Tomita Y, Pan H, Yoshioka Y, Krajewski K, Roller PP, Wang S. Sun H, et al. Among authors: wang s. Bioorg Med Chem Lett. 2005 Feb 1;15(3):793-7. doi: 10.1016/j.bmcl.2004.11.008. Bioorg Med Chem Lett. 2005. PMID: 15664859

5

(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.

Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME. Xu L, et al. Among authors: wang s. Mol Cancer Ther. 2005 Feb;4(2):197-205. Mol Cancer Ther. 2005. PMID: 15713891

6

Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.

Ji M, Chen J, Ding K, Wu X, Varady J, Levant B, Wang S. Ji M, et al. Among authors: wang s. Bioorg Med Chem Lett. 2005 Mar 15;15(6):1701-5. doi: 10.1016/j.bmcl.2005.01.037. Bioorg Med Chem Lett. 2005. PMID: 15745825

7

Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.

Ding K, Chen J, Ji M, Wu X, Varady J, Yang CY, Lu Y, Deschamps JR, Levant B, Wang S. Ding K, et al. Among authors: wang s. J Med Chem. 2005 May 5;48(9):3171-81. doi: 10.1021/jm049031l. J Med Chem. 2005. PMID: 15857123

8

Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL.

Bauer JA, Trask DK, Kumar B, Los G, Castro J, Lee JS, Chen J, Wang S, Bradford CR, Carey TE. Bauer JA, et al. Among authors: wang s. Mol Cancer Ther. 2005 Jul;4(7):1096-104. doi: 10.1158/1535-7163.MCT-05-0081. Mol Cancer Ther. 2005. PMID: 16020667

9

A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.

Tang HJ, Jin X, Wang S, Yang D, Cao Y, Chen J, Gossett DR, Lin J. Tang HJ, et al. Among authors: wang s. Gynecol Oncol. 2006 Feb;100(2):308-17. doi: 10.1016/j.ygyno.2005.08.044. Epub 2005 Oct 4. Gynecol Oncol. 2006. PMID: 16209885

10

Design of novel hexahydropyrazinoquinolines as potent and selective dopamine D3 receptor ligands with improved solubility.

Chen J, Ding K, Levant B, Wang S. Chen J, et al. Among authors: wang s. Bioorg Med Chem Lett. 2006 Jan 15;16(2):443-6. doi: 10.1016/j.bmcl.2005.09.053. Epub 2005 Nov 14. Bioorg Med Chem Lett. 2006. PMID: 16290142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117,297 results

Search Page

Filters